| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 11,280 | 0 | 0 | 11,280 |
| Identifier | Return Reference | Explanation |
|---|---|---|
| General Explanation Supplemental Information for Form 990-PF | 2012 Form 990-PFPart XII, Line 3B, Amounts Set Aside - Cash Distribution TestThe following information is provided in accordance with Treasury Regulation 53.4942(a)-3(b)(7)(ii):a) The Charles A. and Lois H. Miller (the "Foundation") is setting aside funds to develop an endowment fund from which grants will be made to publicly supported charities in furtherance of their long-term supervised charitable projects.b) The amounts set aside for the projects described above will actually be paid within a period of time that ends not more than 60 months after the date of the set-aside.c) The projects described above were completed before the end of the taxable year of the Foundation in which the set-aside is made.d) The distributable amount determined under 4942(d) for the past taxable years in the Foundation's start-up and full payment periods:Year of creation: 2009 Distributable Startup PeriodStart-up Period Amount Percentage Minimum Distribution2009 $ 39,607 00% $ 0 2010 $ 85,880 20% $ 17,1762011 $ 93,178 40% $ 37,2712012 $ 89,450 60% $ 53,6702013 $ 93,912 80% $ 75,130 Total $ 402,027 $ 183,247e) Aggregate distributions for charitable purposes during the Foundation's start-up and full payment periods: Distributions of Start-up Period Cash or Equivalents2009 $ 02010 $ 131,384 2011 $ 136,8252012 $ 126,2252013 $ 124,702Total $ 519,136 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Encana Corp | 15,796 | 9,025 |
| Astrazeneca PLC Spon Adr | 33,455 | 59,370 |
| Coca Cola Co | 41,253 | 82,620 |
| DuPont de Nemours | 29,638 | 97,455 |
| Intel | 30,398 | 54,506 |
| IBM | 27,261 | 56,271 |
| Johnson & Johnson | 60,660 | 109,908 |
| Noble Energy | 31,259 | 88,543 |
| Pfizer | 43,260 | 91,890 |
| Procter & Gamble | 61,204 | 105,833 |
| Thermo Fisher Scientific | 32,352 | 103,778 |
| United Technologies | 76,605 | 113,800 |
| Alpha Natural Resources Inc | 24,978 | 3,941 |
| Celanese Corp New Ser A | 16,994 | 22,124 |
| Dow Chemical | 19,937 | 31,080 |
| Verizon Communications Inc | 22,275 | 29,484 |
| Deutche Bank AG Reeg Shs Ord Eur | 49,930 | 30,632 |
| Suncor Energy Inc New Cad | 24,998 | 21,976 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| HSBC Holdings 8.0% | AT COST | 50,000 | 53,880 |
| JP Morgan Chase Cap 6.7% due 4/2/40 | AT COST | 23,606 | 25,320 |
| Goldman Sachs Group Inc | AT COST | 24,975 | 25,230 |
| Public Storage Ser Q 6.5% | AT COST | 30,000 | 28,044 |
| Public Storage Series R (PSA) | AT COST | 25,000 | 23,350 |
| Stanley Black & Decker Inc | AT COST | 30,000 | 25,656 |
| Royal Bank of Canada | AT COST | 40,000 | 41,320 |
| Apollo Investment Corp | AT COST | 30,000 | 25,390 |
| General Electric Capital CRP 4.7% | AT COST | 30,000 | 23,304 |
| Wells Fargo & Co 5.85% | AT COST | 30,000 | 28,284 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Miscellaneous | 2 |
| Description | Amount |
|---|---|
| FMV adjustment of stock contributions | 30,707 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Forward Miller, LLC | 1,875 | 0 | 0 | 1,875 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Federal taxes | 1,400 | |||
| Foreign Taxes | 356 | 356 |